Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

47

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

A17

A18

TELL ME WHAT YOU SEE: NEW STUDIES IN LUNG IMAGING

BREAKING NEWS IN OSA: NEW APPROACHES AND NEW TRIALS

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 204 A-C (Level 2)

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 202 B (Level 2)

Chairing: P.J. Niedbalski, PhD, Kansas City, KS G. Parraga, PhD, London, Canada Oral Presentations: 9:00 Fully Automatic Quantitative Analysis of Airway-artery Dimensions and Ratios of Normal Chest CT Scans From Infancy Into Adulthood/ H.A.W.M. Tiddens, Rotterdam, Netherlands 9:12 Progressive Airway Wall Thinning and Loss of Total Airway Count After Three-Years in COPD/ P.V. Wyszkiewicz, London, Canada 9:24 Development of a CT-based Algorithm to Link Individual Upper Airways to Downstream Parenchymal Disease: A COPDGene Study/ A.J. Bell, Ann Arbor, MI 9:36 Age-related Changes in Ventilation and Perfusion Ratio (V’/Q’) Assessed With Dual-Energy CT: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study/ E.A. Hermann, New York, NY 9:48 Computational Fluid Dynamics Analysis Demonstrates Impact of Mucus Plugging on Modifying Airway Dimensions Leading to Increased Airway Resistance and Reduced Lung Deformation in Asthma/ J. Choi, Kansas City, KS 10:00 129Xe Gas-exchange MRI and CT Pulmonary Vascular Abnormalities in GINA 4-5 Asthma/ A.M. Matheson, London, Canada 10:12 Hyperpolarized 129 Xe MRI Visualizes Lung Function Impairment in Suspected Inflammatory Interstitial Lung Disease/ E. Graumann, Kansas City, KS 10:24 Validation of X-ray Velocimetry With Pneumotachograph to Assess Respiratory Physiology/ A.E. Tombleson, Larchmont, NY 10:36 Homothety Ratio of Airway Diameters Is Associated With Respiratory Morbidity and Mortality in Chronic Obstructive Pulmonary Disease/ S. Bodduluri, Birmingham, AL

Chairing: M. Cao, DO, Stanford, CA

N.A. Shah, MD, MPH, MSci, New York, NY S.R. Patel, MD, MS, ATSF, Pittsburgh, PA S. Pamidi, MD, MSci, Montreal, Canada

Oral Presentations: 9:00 Treatment of Sleep Apnoea Early After Myocardial Infarction With Adaptive Servo-ventilation (TEAM-ASV I): A Multicentre Randomised Controlled Trial/ M. Arzt, Regensburg, Germany 9:12 Effects of Positive Airway Pressure on Glycemic Variability in Persons With Type 2 Diabetes and Obstructive Sleep Apnea/ R.N. Aurora, New York, NY 9:24 Cognition and Obstructive Sleep Apnea in Parkinson’s Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP Trial)/ A.C. Lajoie, Québec, Canada 9:36 Oral Appliance Therapy as First-line Treatment Option in Patients Diagnosed With Moderate to Severe Obstructive Sleep Apnea/ M. Dieltjens, Antwerp, Belgium 9:48 Optimal Dose and Efficacy of Acetazolamide as Obstructive Sleep Apnea Treatment/ S. Hellemans, Wilrijk, Belgium 10:00 The Oral Agent AD109 Improves Objective and Subjective Outcomes in Obstructive Sleep Apnea Patients. Results From the Mariposa Study, a Randomized, Controlled Clinical Trial/ P. Schweitzer, Chesterfield, MO 10:12 Sustained Therapeutic Benefits for at Least 3 Years in the THN3 Randomized, Controlled Trial of Targeted Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea/ A.R. Schwartz, Philadelphia, PA 10:24 Loop Gain as a Predictor of Blood Pressure Response in Patients With Obstructive Sleep Apnea: Secondary Analysis of the Heartbeat Trial/ L. McGinnis, La Jolla, CA 10:36 The Impact of Night-to-Night Variability in Obstructive Sleep Apnea Severity and Classification Status on the

Ability of Research Trials to Detect Incident Hypertension/ B. Lechat, Adelaide, Australia

Featured Speaker: 10:48

Translation of Novel Approaches to OSA Care into Mainstream Clinical Practice/ C.L. Chai-Coetzer, Adelaide, Australia

ATS 2023 • Washington, DC